Company intelligence / Profile preview
SkinBioTherapeutics
Newcastle upon Tyne, United Kingdomskinbiotherapeutics.com ↗
- Ownership
- Private
- Employees
- ~15
- Development stage
- Other
01
Overview
The company has shown that its SkinBiotix® platform can improve the barrier effect of skin models, protect skin from infection, and repair skin models. Proof of principle studies have demonstrated beneficial attributes applicable to multiple areas of skin health[1][2].
- Therapeutic areas
- Dermatology
- Modalities
- Probiotic bacteria lysates
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Croda Plc (for development of SkinBiotix as an active ingredient for the skincare/cosmetic industry)[5]
Beyond the preview
Go deeper on SkinBioTherapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SkinBioTherapeutics.